Toyota - Torrance, CA since Apr 2009
Sr. Product Planner, Lexus Division
Toyota Motor Sales, USA - Torrance, CA May 2006 - Apr 2009
Graduate Management Associate Internal Consulting Program
Roche Diagnostics, Inc. - Greater Chicago Area Feb 2002 - Feb 2004
Regional Business Manager, MyDoc.com Division
March Networks Corporation - Greater Chicago Area Jun 2000 - Jan 2002
Regional Sales Manager, Healthcare Applications Division
Eli Lilly and Company - Greater Chicago Area Aug 1997 - May 2000
Senior Pharmaceutical Sales Representative, Primary Care Division
Education:
Georgetown University - The McDonough School of Business 2005 - 2007
MBA, General Management with Marketing Strategy focus
Universidad Pontificia de Salamanca 1996 - 1997
Illinois Wesleyan University 1993 - 1997
BA, Business Administration and Economics Double Major; Spanish minor
Skills:
Product Development Business Planning Data Analysis Marketing Research Strategic Planning Product Management Product Marketing Product Strategy Product Launch Marketing Strategy Corporate Strategy Formulation Sales Sales Management Automotive Competitive Analysis Program Management
Honor & Awards:
Undergraduate: Research Honors in Economics, Outstanding Business Student Award, Dean's List
MBA: Beta Gamma Sigma: Graduated with Honors
David W. Henry - Menlo Park CA Michael Cory - Palo Alto CA
Assignee:
Stanford Research Institute - Menlo Park PA
International Classification:
C07D40506
US Classification:
260240A
Abstract:
N-substituted 2-[2-(5-nitro-2-furyl)vinyl]imidazoles having the structure ##STR1## wherein R represents mono- or dimethoxybenzyl, pyridylmethyl, N,N-dimethylaminobenzyl or phenoxypropyl. A preferred compound is 1-(4-methoxybenzyl)-2-[2-(5-nitro-2-furyl)vinyl]imidazole. The compounds have utility as antischistosomal chemotherapeutic agents.
Nitroimidazoles Of Low Toxicity And High Activity As Radiosensitizers Of Hypoxic Tumor Cells
William W. Lee - Palo Alto CA J. Martin Brown - Stanford CA Abelardo P. Martinez - San Jose CA Michael J. Cory - Chapel Hill NC
Assignee:
The United States of America as represented by the Secretary of the Department of Health and Human Services - Washington DC
International Classification:
A61K 31415
US Classification:
424273R
Abstract:
Two compounds represented by the formula ##STR1## wherein R is hydrogen or a 2-hydroxyethyl radical are reported to have minimum penetration into the brain and nerve tissues combined with maximum penetration into hypoxic tumor cells. This combination of properties makes these compounds the optimal radiosensitizers among electron-affinic 1-substituted 2-nitroinidazoles.